Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4059-06 phase II tirabrutinib in refractory pemphigus
jRCT2080224170Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tirabrutinib in pemphigus, sponsored by Ono Pharmaceutical. Started Dec 2018; status: completed.
02
Drugs
tirabrutinib
03
Conditions
pemphigus
Beyond the preview
Go deeper on jRCT2080224170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224170.